CCC(C(=O)Nc1cccc(C#N)c1)n1c(=O)c(-c2ccccc2NC(C)=O)nc2ccccc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?